{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T14:17:00Z","timestamp":1794925020263,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"7932","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,10,20]]},"DOI":"10.1038\/s41586-022-05258-z","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T11:03:59Z","timestamp":1664363039000},"page":"582-591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":270,"title":["Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity"],"prefix":"10.1038","volume":"610","author":[{"given":"Anat Levit","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle N.","family":"Confair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuglae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Barros-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona M.","family":"Rodriguiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Sang","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-3027","authenticated-orcid":false,"given":"Tao","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-9413","authenticated-orcid":false,"given":"John D.","family":"McCorvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Kamber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-0653","authenticated-orcid":false,"given":"James P.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7747-6782","authenticated-orcid":false,"given":"Luan Carvalho","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir M.","family":"Pogorelov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8227-2071","authenticated-orcid":false,"given":"Jeffrey F.","family":"DiBerto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Slocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8173-3326","authenticated-orcid":false,"given":"Jain Manish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-680X","authenticated-orcid":false,"given":"Michael J.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouliana","family":"Panova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpay B.","family":"Seven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn Q.","family":"Wetsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-7397","authenticated-orcid":false,"given":"William C.","family":"Wetsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1195-6417","authenticated-orcid":false,"given":"John J.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0238-7846","authenticated-orcid":false,"given":"Georgios","family":"Skiniotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-7367","authenticated-orcid":false,"given":"Brian K.","family":"Shoichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-6520","authenticated-orcid":false,"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9320-5512","authenticated-orcid":false,"given":"Jonathan A.","family":"Ellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"5258_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/d41586-019-00145-6","volume":"566","author":"DE Gloriam","year":"2019","unstructured":"Gloriam, D. E. Bigger is better in virtual drug screens. Nature 566, 193\u2013194 (2019).","journal-title":"Nature"},{"key":"5258_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","volume":"566","author":"J Lyu","year":"2019","unstructured":"Lyu, J. et al. Ultra-large library docking for discovering new chemotypes. Nature 566, 224\u2013229 (2019).","journal-title":"Nature"},{"key":"5258_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-020-2117-z","volume":"580","author":"C Gorgulla","year":"2020","unstructured":"Gorgulla, C. et al. An open-source drug discovery platform enables ultra-large virtual screens. Nature 580, 663\u2013668 (2020).","journal-title":"Nature"},{"key":"5258_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41586-020-2027-0","volume":"579","author":"RM Stein","year":"2020","unstructured":"Stein, R. M. et al. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms. Nature 579, 609\u2013614 (2020).","journal-title":"Nature"},{"key":"5258_CR5","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1021\/ja2119833","volume":"134","author":"S Duttwyler","year":"2012","unstructured":"Duttwyler, S., Lu, C., Rheingold, A. L., Bergman, R. G. & Ellman, J. A. Highly diastereoselective synthesis of tetrahydropyridines by a C\u2013H activation\u2013cyclization\u2013reduction cascade. JACS 134, 4064\u20134067 (2012).","journal-title":"JACS"},{"key":"5258_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1230704","volume":"339","author":"S Duttwyler","year":"2013","unstructured":"Duttwyler, S. et al. Proton donor acidity controls selectivity in nonaromatic nitrogen heterocycle synthesis. Science 339, 678\u2013682 (2013).","journal-title":"Science"},{"key":"5258_CR7","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1021\/ja312311k","volume":"135","author":"MA Ischay","year":"2013","unstructured":"Ischay, M. A., Takase, M. K., Bergman, R. G. & Ellman, J. A. Unstabilized azomethine ylides for the stereoselective synthesis of substituted piperidines, tropanes, and azabicyclo[3.1.0] systems. JACS 135, 2478\u20132481 (2013).","journal-title":"JACS"},{"key":"5258_CR8","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1021\/jm901241e","volume":"52","author":"F Lovering","year":"2009","unstructured":"Lovering, F., Bikker, J. & Humblet, C. Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem. 52, 6752\u20136756 (2009).","journal-title":"J. Med. Chem."},{"key":"5258_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrd.2018.116","volume":"17","author":"J Bostr\u00f6m","year":"2018","unstructured":"Bostr\u00f6m, J., Brown, D. G., Young, R. J. & Keser\u00fc, G. M. Expanding the medicinal chemistry synthetic toolbox. Nat. Rev. Drug Discov. 17, 709\u2013727 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"5258_CR10","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling, T. & Irwin, J. J. ZINC 15\u2014ligand discovery for everyone. J. Chem. Inf. Model. 55, 2324\u20132337 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"5258_CR11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1021\/ci010366a","volume":"41","author":"TI Oprea","year":"2001","unstructured":"Oprea, T. I., Davis, A. M., Teague, S. J. & Leeson, P. D. Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci. 41, 1308\u20131315 (2001).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"5258_CR12","doi-asserted-by":"crossref","unstructured":"Berger, M., Gray, J. A. & Roth, B. L. The expanded biology of serotonin. Annu. Rev. Med. 60, 355\u2013366 (2009).","DOI":"10.1146\/annurev.med.60.042307.110802"},{"key":"5258_CR13","doi-asserted-by":"crossref","unstructured":"McCorvy, J. D. & Roth, B. L. Structure and function of serotonin G protein-coupled receptors. Pharmacol. Ther. 150, 129\u2013142 (2015).","DOI":"10.1016\/j.pharmthera.2015.01.009"},{"key":"5258_CR14","doi-asserted-by":"crossref","unstructured":"Meltzer, H. Y. & Roth, B. L. Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs. J. Clin. Invest. 123, 4986\u20134991 (2013).","DOI":"10.1172\/JCI70678"},{"key":"5258_CR15","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","volume":"182","author":"K Kim","year":"2020","unstructured":"Kim, K. et al. Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor. Cell 182, 1574\u20131588 (2020).","journal-title":"Cell"},{"key":"5258_CR16","doi-asserted-by":"crossref","unstructured":"Carhart-Harris, R. et al. Trial of psilocybin versus escitalopram for depression. N. Engl. J. Med. 384, 1402\u20131411 (2021).","DOI":"10.1056\/NEJMoa2032994"},{"key":"5258_CR17","doi-asserted-by":"crossref","unstructured":"Roth, B. L. Drugs and valvular heart disease. N. Engl. J. Med. 356, 6\u20139 (2007).","DOI":"10.1056\/NEJMp068265"},{"key":"5258_CR18","doi-asserted-by":"crossref","unstructured":"Rothman, R. B. et al. Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102, 2836\u20132841 (2000).","DOI":"10.1161\/01.CIR.102.23.2836"},{"key":"5258_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1126\/science.1232808","volume":"340","author":"D Wacker","year":"2013","unstructured":"Wacker, D. et al. Structural features for functional selectivity at serotonin receptors. Science 340, 615\u2013619 (2013).","journal-title":"Science"},{"key":"5258_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","volume":"168","author":"D Wacker","year":"2017","unstructured":"Wacker, D. et al. Crystal structure of an LSD-Bound human serotonin receptor. Cell 168, 377\u2013389 (2017).","journal-title":"Cell"},{"key":"5258_CR21","unstructured":"Andrade, R. et al. IUPHAR\/BPS Guide to Pharmacology Vol. 2019 (4) (2019)."},{"key":"5258_CR22","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger, M. M., Carchia, M., Irwin, J. J. & Shoichet, B. K. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J. Med. Chem. 55, 6582\u20136594 (2012).","journal-title":"J. Med. Chem."},{"key":"5258_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature15699","volume":"527","author":"XP Huang","year":"2015","unstructured":"Huang, X. P. et al. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature 527, 477\u2013483 (2015).","journal-title":"Nature"},{"key":"5258_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nchembio.2334","volume":"13","author":"K Lansu","year":"2017","unstructured":"Lansu, K. et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat. Chem. Biol. 13, 529\u2013536 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"5258_CR25","doi-asserted-by":"crossref","unstructured":"Ballesteros, J. A. & Weinstein, H. in Methods in Neurosciences Vol. 25 (ed. Sealfon, S. C.) 366\u2013428 (Academic, 1995).","DOI":"10.1016\/S1043-9471(05)80049-7"},{"key":"5258_CR26","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1021\/acs.jmedchem.5b02008","volume":"59","author":"JJ Irwin","year":"2016","unstructured":"Irwin, J. J. & Shoichet, B. K. Docking screens for novel ligands conferring new biology. J. Med. Chem. 59, 4103\u20134120 (2016).","journal-title":"J. Med. Chem."},{"key":"5258_CR27","doi-asserted-by":"publisher","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento, A. P. et al. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 42, D1083\u2013D1090 (2014).","journal-title":"Nucleic Acids Res."},{"key":"5258_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-021-03376-8","volume":"592","author":"P Xu","year":"2021","unstructured":"Xu, P. et al. Structural insights into the lipid and ligand regulation of serotonin receptors. Nature 592, 469\u2013473 (2021).","journal-title":"Nature"},{"key":"5258_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acsmedchemlett.7b00212","volume":"8","author":"P Lassalas","year":"2017","unstructured":"Lassalas, P. et al. Evaluation of oxetan-3-ol, thietan-3-ol, and derivatives thereof as bioisosteres of the carboxylic acid functional group. ACS Med. Chem. Lett. 8, 864\u2013868 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"5258_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nsmb.3014","volume":"22","author":"WK Kroeze","year":"2015","unstructured":"Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362\u2013369 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"5258_CR31","doi-asserted-by":"publisher","first-page":"e9019","DOI":"10.1371\/journal.pone.0009019","volume":"5","author":"TS Ray","year":"2010","unstructured":"Ray, T. S. Psychedelics and the human receptorome. PLoS ONE 5, e9019 (2010).","journal-title":"PLoS ONE"},{"key":"5258_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96736-3","volume":"11","author":"RM Rodriguiz","year":"2021","unstructured":"Rodriguiz, R. M. et al. LSD-stimulated behaviors in mice require beta-arrestin 2 but not beta-arrestin 1. Sci. Rep. 11, 17690 (2021).","journal-title":"Sci. Rep."},{"key":"5258_CR33","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1021\/acs.accounts.7b00083","volume":"50","author":"R Abel","year":"2017","unstructured":"Abel, R., Wang, L., Harder, E. D., Berne, B. J. & Friesner, R. A. Advancing drug discovery through enhanced free energy calculations. Acc. Chem. Res. 50, 1625\u20131632 (2017).","journal-title":"Acc. Chem. Res."},{"key":"5258_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06002-w","volume":"9","author":"S Maeda","year":"2018","unstructured":"Maeda, S. et al. Development of an antibody fragment that stabilizes GPCR\/G-protein complexes. Nat. Commun. 9, 3712 (2018).","journal-title":"Nat. Commun."},{"key":"5258_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.str.2020.04.018","volume":"28","author":"MJ Robertson","year":"2020","unstructured":"Robertson, M. J., van Zundert, G. C. P., Borrelli, K. & Skiniotis, G. GemSpot: a pipeline for robust modeling of ligands into Cryo-EM maps. Structure 28, 707\u2013716 (2020).","journal-title":"Structure"},{"key":"5258_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.abl8615","volume":"375","author":"D Cao","year":"2022","unstructured":"Cao, D. et al. Structure-based discovery of nonhallucinogenic psychedelic analogs. Science 375, 403\u2013411 (2022).","journal-title":"Science"},{"key":"5258_CR37","doi-asserted-by":"crossref","unstructured":"Meltzer, H. Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21, 106S\u2013115S (1999).","DOI":"10.1038\/sj.npp.1395370"},{"key":"5258_CR38","doi-asserted-by":"crossref","unstructured":"Nutt, D., Erritzoe, D. & Carhart-Harris, R. Psychedelic psychiatry\u2019s brave new world. Cell 181, 24\u201328 (2020).","DOI":"10.1016\/j.cell.2020.03.020"},{"key":"5258_CR39","doi-asserted-by":"crossref","unstructured":"Corne, S. J. & Pickering, R. W. A possible correlation between drug-induced hallucinations in man and a behavioural response in mice. Psychopharmacologia 11, 65\u201378 (1967).","DOI":"10.1007\/BF00401509"},{"key":"5258_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1073\/pnas.41.6.338","volume":"41","author":"DW Woolley","year":"1955","unstructured":"Woolley, D. W. Production of abnormal (Psychotic?) Behavior in mice with lysergic acid diethylamide, and its partial prevention with cholinergic drugs and serotonin. Proc. Natl Acad. Sci. USA 41, 338\u2013344 (1955).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5258_CR41","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/107385849900500414","volume":"5","author":"BL Roth","year":"1999","unstructured":"Roth, B. L., Willins, D. L., Kristiansen, K. & Kroeze, W. K. Activation is hallucinogenic and antagonism is therapeutic: role of 5-HT2A receptors in atypical antipsychotic drug actions. Neuroscientist 5, 254\u2013262 (1999).","journal-title":"Neuroscientist"},{"key":"5258_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0269881114555249","volume":"29","author":"P Gasser","year":"2015","unstructured":"Gasser, P., Kirchner, K. & Passie, T. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. J. Psychopharmacol. 29, 57\u201368 (2015).","journal-title":"J. Psychopharmacol."},{"key":"5258_CR43","doi-asserted-by":"publisher","first-page":"112749","DOI":"10.1016\/j.psychres.2020.112749","volume":"284","author":"SB Goldberg","year":"2020","unstructured":"Goldberg, S. B., Pace, B. T., Nicholas, C. R., Raison, C. L. & Hutson, P. R. The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis. Psychiatry Res. 284, 112749 (2020).","journal-title":"Psychiatry Res."},{"key":"5258_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","volume":"68","author":"CS Grob","year":"2011","unstructured":"Grob, C. S. et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch. Gen. Psychiatry 68, 71\u201378 (2011).","journal-title":"Arch. Gen. Psychiatry"},{"key":"5258_CR45","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross, S. et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J. Psychopharmacol. 30, 1165\u20131180 (2016).","journal-title":"J. Psychopharmacol."},{"key":"5258_CR46","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","volume":"109","author":"LX Shao","year":"2021","unstructured":"Shao, L. X. et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron 109, 2535\u20132544.e4 (2021).","journal-title":"Neuron"},{"key":"5258_CR47","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/ar800236t","volume":"42","author":"WL Jorgensen","year":"2009","unstructured":"Jorgensen, W. L. Efficient drug lead discovery and optimization. Acc. Chem. Res. 42, 724\u2013733 (2009).","journal-title":"Acc. Chem. Res."},{"key":"5258_CR48","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1021\/acs.jcim.0c00276","volume":"60","author":"KJ Cutrona","year":"2020","unstructured":"Cutrona, K. J., Newton, A. S., Krimmer, S. G., Tirado-Rives, J. & Jorgensen, W. L. Metadynamics as a postprocessing method for virtual screening with application to the pseudokinase domain of JAK2. J. Chem. Inf. Model. 60, 4403\u20134415 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"5258_CR49","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41557-019-0409-4","volume":"12","author":"NI Saper","year":"2020","unstructured":"Saper, N. I. et al. Nickel-catalysed anti-Markovnikov hydroarylation of unactivated alkenes with unactivated arenes facilitated by non-covalent interactions. Nat. Chem. 12, 276\u2013283 (2020).","journal-title":"Nat. Chem."},{"key":"5258_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-62703-646-7_17","volume":"1079","author":"J Pei","year":"2014","unstructured":"Pei, J. & Grishin, N. V. PROMALS3D: multiple protein sequence alignment enhanced with evolutionary and three-dimensional structural information. Methods Mol. Biol. 1079, 263\u2013271 (2014).","journal-title":"Methods Mol. Biol."},{"key":"5258_CR51","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1126\/science.1244142","volume":"342","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. Serial femtosecond crystallography of G protein-coupled receptors. Science 342, 1521\u20131524 (2013).","journal-title":"Science"},{"key":"5258_CR52","doi-asserted-by":"publisher","first-page":"5.6.1","DOI":"10.1002\/0471250953.bi0506s47","volume":"47","author":"B Webb","year":"2014","unstructured":"Webb, B. & Sali, A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinform. 47, 5.6.1\u20135.6.30 (2014).","journal-title":"Curr. Protoc. Bioinform."},{"key":"5258_CR53","doi-asserted-by":"publisher","first-page":"e75992","DOI":"10.1371\/journal.pone.0075992","volume":"8","author":"RG Coleman","year":"2013","unstructured":"Coleman, R. G., Carchia, M., Sterling, T., Irwin, J. J. & Shoichet, B. K. Ligand pose and orientational sampling in molecular docking. PLoS ONE 8, e75992 (2013).","journal-title":"PLoS ONE"},{"key":"5258_CR54","doi-asserted-by":"publisher","first-page":"D1054","DOI":"10.1093\/nar\/gkv1037","volume":"44","author":"C Southan","year":"2016","unstructured":"Southan, C. et al. The IUPHAR\/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res. 44, D1054\u2013D1068 (2016).","journal-title":"Nucleic Acids Res."},{"key":"5258_CR55","doi-asserted-by":"crossref","unstructured":"Salomon-Ferrer, R., Case, D. A. & Walker, R. C. An overview of the Amber biomolecular simulation package. WIREs Comput. Mol. Sci. 3, 198\u2013210 (2013).","DOI":"10.1002\/wcms.1121"},{"key":"5258_CR56","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/ci100214a","volume":"50","author":"MM Mysinger","year":"2010","unstructured":"Mysinger, M. M. & Shoichet, B. K. Rapid context-dependent ligand desolvation in molecular docking. J. Chem. Inf. Model. 50, 1561\u20131573 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"5258_CR57","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0022-2836(02)00777-5","volume":"322","author":"BQ Wei","year":"2002","unstructured":"Wei, B. Q., Baase, W. A., Weaver, L. H., Matthews, B. W. & Shoichet, B. K. A model binding site for testing scoring functions in molecular docking. J. Mol. Biol. 322, 339\u2013355 (2002).","journal-title":"J. Mol. Biol."},{"key":"5258_CR58","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1006\/jmbi.1998.2401","volume":"285","author":"JM Word","year":"1999","unstructured":"Word, J. M., Lovell, S. C., Richardson, J. S. & Richardson, D. C. Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J. Mol. Biol. 285, 1735\u20131747 (1999).","journal-title":"J. Mol. Biol."},{"key":"5258_CR59","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0006-3495(98)77566-6","volume":"75","author":"K Gallagher","year":"1998","unstructured":"Gallagher, K. & Sharp, K. Electrostatic contributions to heat capacity changes of DNA-ligand binding. Biophys. J. 75, 769\u2013776 (1998).","journal-title":"Biophys. J."},{"key":"5258_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/bip.360360210","volume":"36","author":"KA Sharp","year":"1995","unstructured":"Sharp, K. A. Polyelectrolyte electrostatics: salt dependence, entropic, and enthalpic contributions to free energy in the nonlinear Poisson\u2013Boltzmann model. Biopolymers 36, 227\u2013243 (1995).","journal-title":"Biopolymers"},{"key":"5258_CR61","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"5258_CR62","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson, M. H. M., S\u00f8ndergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: consistent treatment of internal and surface residues in empirical PKa predictions. J. Chem. Theory Comput. 7, 525\u2013537 (2011).","journal-title":"J. Chem. Theory Comput."},{"key":"5258_CR63","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/ja512751q","volume":"137","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J. Am. Chem. Soc. 137, 2695\u20132703 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"5258_CR64","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","volume":"16","author":"RHJ Olsen","year":"2020","unstructured":"Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841\u2013849 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"5258_CR65","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3959(01)00259-7","volume":"92","author":"Y Zhang","year":"2001","unstructured":"Zhang, Y., Yang, Z., Gao, X. & Wu, G. The role of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors in modulating spinal nociceptive transmission in normal and carrageenan-injected rats. Pain 92, 201\u2013211 (2001).","journal-title":"Pain"},{"key":"5258_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"5258_CR67","doi-asserted-by":"publisher","first-page":"e42166","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"5258_CR68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"5258_CR69","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"5258_CR70","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D"},{"key":"5258_CR71","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."},{"key":"5258_CR72","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"5258_CR73","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1523\/JNEUROSCI.4388-06.2007","volume":"27","author":"M Fukui","year":"2007","unstructured":"Fukui, M. et al. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J. Neurosci. 27, 10520\u201310529 (2007).","journal-title":"J. Neurosci."},{"key":"5258_CR74","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/jnc.14209","volume":"143","author":"I Berezniuk","year":"2017","unstructured":"Berezniuk, I. et al. ProSAAS-derived peptides are regulated by cocaine and are required for sensitization to the locomotor effects of cocaine. J. Neurochem. 143, 268\u2013281 (2017).","journal-title":"J. Neurochem."},{"key":"5258_CR75","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1038\/npp.2017.52","volume":"42","author":"VM Pogorelov","year":"2017","unstructured":"Pogorelov, V. M. et al. 5-HT2C agonists modulate schizophrenia-like behaviors in mice. Neuropsychopharmacology 42, 2163\u20132177 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"5258_CR76","doi-asserted-by":"publisher","first-page":"17362","DOI":"10.1073\/pnas.1314698110","volume":"110","author":"WC Wetsel","year":"2013","unstructured":"Wetsel, W. C. et al. Disruption of the expression of the proprotein convertase PC7 reduces BDNF production and affects learning and memory in mice. Proc. Natl Acad. Sci. USA 110, 17362\u201317367 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5258_CR77","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1021\/acsomega.9b03430","volume":"5","author":"T Yempala","year":"2020","unstructured":"Yempala, T. et al. Dibenzofuranylethylamines as 5-HT2A\/2C receptor agonists. ACS Omega 5, 2260\u20132266 (2020).","journal-title":"ACS Omega"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05258-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T10:22:39Z","timestamp":1671099759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05258-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":77,"journal-issue":{"issue":"7932","published-print":{"date-parts":[[2022,10,20]]}},"alternative-id":["5258"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-05258-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742343684.793595757","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the surname of Javier Gonz\u00e1lez-Maeso in the Peer review information was misspelt and has now been amended.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A.E., D.N.C., O.S.K., B.L.R., K.K., B.K.S., A.L.K. and J.J.I. have filed a patent\u00a0(W02022067165) around the new THP agonists through their universities. B.K.S. is a founder of Epiodyne and, with J.J.I., BlueDolphin. B.K.S., J.J.I. and G.S. are co-founders of Deep Apple. B.L.R. is a scientific founder of Onsero Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}